Talking Biotech with Dr. Kevin Folta

How AI Has Changed the Business of Drug Discovery - Dr. Michael Zaiac

Apr 22, 2023

34:21

Creator website

AI Chapters

Episode notes

Introduction

4min

The Three Phases of Digitalization in the Pharmaceutical Industry

3min

How Novartis Is Using Digital Technology to Better Identify Patients

2min

The Advantages of Insilico Drug Discovery

3min

The Role of Artificial Intelligence in Drug Discovery

2min

The Challenges and Benefits of Using Real World Data

2min

The Impact of AI on Clinical Trial Enrollment

3min

Digital Technology Promotes Diversity in Clinical Trials

4min

AI to Generate Predictive Biomarkers in Personalized Medicine

3min

10.

The Complexity of Genomic Overlays

2min

11.

The Future of Technology Integration and Pharmaceutical R&D

3min

12.

How Digital Technology Has Impacted Patient Engagement Communication in Medical Affairs

3min

13.

The Future of AI Drug Discovery in Novartis

2min

The companies on the front edge of pharmaceutical development have identified the value of massive data sets in the future of drug design. Ironically, personalization of therapies will be improved tremendously through examination of massive data sets. Dr. Michael Zaizac from Novartis of Europe discusses how his company has they have integrated artificial intelligence and analysis of patient data sets for new discoveries in patient care.